First CTA authorization marks nChroma’s transition to a clinical-stage company; first patient dosing in Phase 1/2 trial planned for early 2026 Preclinical studies demonstrated CRMA-1001 delivers ...
nChroma Bio Receives Authorization of Clinical Trial Application to Initiate First-in-Human Study for Epigenetic Silencer CRMA-1001 for the Treatment of Chronic Hepatitis B First CTA authorization ...
BOSTON, December 16, 2025--(BUSINESS WIRE)--nChroma Bio ("nChroma"), a genetic medicines company advancing in vivo delivery of innovative cargoes to overcome the limitations of existing therapies, ...
Stop Procrastination, Start Studying 2025: Procrastination is something almost every student faces, especially when tasks seem endless or difficult. It usually begins with the thought, "I'll do it ...
Last week, OpenAI launched “study mode” in its chatbot, aimed directly at the student market. It’s meant to behave more like a tutor than a machine that spits out answers; it uses the Socratic method, ...
As the new school year approaches, Google announced on Wednesday that it’s launching a new tool called Guided Learning within Gemini. The tool sort of functions like an AI tutor, as it’s designed to ...
I'm on the record as an optimist for Y-mAbs Therapeutics, Inc. (YMAB), with particular enthusiasm for what I was seeing with their modular SADA platform. To date, that enthusiasm hasn't really borne ...
Students are using ChatGPT more than ever — and ChatGPT knows it. Last week, OpenAI launched "study mode" in its chatbot, aimed directly at the student market. It's meant to behave more like a tutor ...
OpenAI has launched a new “study mode” for ChatGPT that’s designed to help students better understand complex topics—but instead of dishing out direct answers, study mode employs the Socratic method ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results